Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer

JACC CardioOncol. 2023 Jun 20;5(3):292-297. doi: 10.1016/j.jaccao.2023.05.004. eCollection 2023 Jun.
No abstract available

Keywords: anthracycline; breast cancer; cancer survivorship; cardiomyopathy; heart failure; prevention.

Publication types

  • Review